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Objective: Spinal cord ischemia (SCI) is a potentially devastating complication of thoracic endovascular aortic repair
(TEVAR) that can result in varying degrees of short-term and permanent disability. This study was undertaken to
describe the clinical outcomes, long-term functional impact, and inﬂuence on survival of SCI after TEVAR.
Methods: A retrospective review of all TEVAR patients at the University of Florida from 2000 to 2011 was performed to
identify individuals experiencing SCI, deﬁned by any new lower extremity neurologic deﬁcit not attributable to another
cause. SCI was dichotomized into immediate or delayed onset, with immediate onset deﬁned as SCI noted upon
awakening from anesthesia, and delayed characterized as a period of normal function, followed by development of
neurologic injury. Ambulatory status was determined using database query, record review, and phone interviews with
patients and/or family. Mortality was estimated using life-table analysis.
Results: A total of 607 TEVARs were performed for various indications, with 57 patients (9.4%) noted to have post-
operative SCI (4.3% permanent). SCI patients were more likely to be older (63.9 6 15.6 vs 70.5 6 11.2 years; P[ .002)
and have a number of comorbidities, including chronic obstructive pulmonary disease, hypertension, dyslipidemia, and
cerebrovascular disease (P < .0001). At some point in their care, a cerebrospinal ﬂuid drain was placed in 54 patients
(95%), with 54% placed postoperatively. In-hospital mortality was 8.8% for the entire cohort (SCI vs no SCI; P [ .45).
SCI developed immediately in 12 patients, delayed onset in 40, and indeterminate in ﬁve patients due to indiscriminate
timing from postoperative sedation. Three patients (25%) with immediate SCI had measurable functional improvement
(FI), whereas 28 (70%) of the delayed-onset patients experienced some degree of neurologic recovery (P[ .04). Of the 34
patients with complete data available, 26 (76%) reported quantiﬁable FI, but only 13 (38%) experienced return to their
preoperative baseline. Estimated mean (6 standard error) survival for patients with and without SCI was 37.2 6 4.5 and
71.6 6 3.9 months (P < .0006), respectively. Patients with FI had a mean survival of 53.9 6 5.9 months compared with
9.6 6 3.6 months for those without improvement (P < .0001). Survival and return of neurologic function were not
signiﬁcantly different when patients with preoperative and postoperative cerebrospinal ﬂuid drains were compared.
Conclusions: The minority of patients experience complete return to baseline function after SCI with TEVAR, and
outcomes in patients without early functional recovery are particularly dismal. Patients experiencing delayed SCI are more
likely to have FI and may anticipate similar life-expectancy with neurologic recovery compared with patients without SCI.
Timing of drain placement does not appear to have an impact on postdischarge FI or long-term mortality. (J Vasc Surg
2013;58:635-42.)Thoracic endovascular aortic repair (TEVAR) has be-
come a mainstay of therapy for diseases of the thoracic aorta
over the last decade. Despite being less invasive than open
aortic repair, TEVAR still results in spinal cord ischemia
(SCI) in 2% to 15% of patients.1-4 A variety of patient and
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://dx.doi.org/10.1016/j.jvs.2013.02.036been reported, including aortic treatment length,3,5 left
subclavian artery coverage,1,5 obesity,6 blood loss,6 proce-
dural urgency,6 adjunct procedures (eg, conduit, emboliza-
tion),6 renal insufﬁciency,7 hypotension,5 and indication for
operation.8 Further, a number of adjunctive therapies for the
prevention and treatment of SCI after TEVAR have been re-
ported and include cerebrospinal ﬂuid (CSF) drainage, left
subclavian or hypogastric artery revascularization, augmen-
tation of oxygen delivery, and pharmacologically induced
hypertension.9 Despite increased awareness of this problem
and judicious application of these interventions, some
patients continue to suffer this devastating complication.
SCI leads to varying degrees of short-term and long-
term disability, ranging from mild transient paraparesis to
permanent ﬂaccid paralysis, and the occurrence of this
complication has a known negative impact on long-term
survival.1,10 Additionally, previous reports have suggested
that neurologic recovery with delayed paraplegia has
a more favorable outcome compared with immediate para-
plegia,7,9,11-13 but small sample sizes make it difﬁcult to
draw deﬁnitive conclusions about the natural history of635
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the long-term functional outcome of patients with SCI
after TEVAR or the prognostic implications of the degree
and speed of functional recovery after SCI.
The purpose of this study was to deﬁne the outcomes
of patients experiencing SCI after TEVAR and determine
differences in the evolution of long-term functional
recovery and the effect on survival.
METHODS
This study was approved by the University of Florida
College of Medicine Institutional Review Board.
Patients and database. All TEVAR patients at the
University of Florida between September 2000 and
November 2011 were identiﬁed from a prospectively main-
tained endovascular aortic database. Patients diagnosed
with postoperative SCI were further analyzed and com-
pared with patients without SCI. Patients with neurologic
deﬁcits conﬁrmed to be secondary to stroke or peripheral
neuropathy were excluded from the analysis. Demo-
graphics, comorbidities, history of previous aortic surgery,
and preoperative ambulatory status were determined by
review of the electronic medical record. Procedure-
related data pertaining to indication, aortic coverage
zone(s), device type, timing of spinal drain use, anesthetic
classiﬁcation, and adjunct use were obtained from the
database. Comorbidities and complications were deﬁned
and retrospectively recorded using the Society for Vascular
Surgery reporting guidelines.14
TEVAR technique and procedural adjuncts. The
endovascular technique, sequence of graft implantation,
need for adjuncts, and spinal drain use was left to the judg-
ment of the operating surgeon. Typically, patients with
>150 mm of aortic coverage,3 previous open or endovas-
cular aortic surgery,15 or an unrepaired infrarenal aneu-
rysm15 were considered high-risk for paraplegia and
preoperative CSF drainage was used. Perioperative
management of the spinal drain was based on a previously
published standardized protocol,3,16 and management of
symptomatic patients is brieﬂy outlined below. Patients
undergoing elective repair were systemically heparinized
(100 U/kg) to achieve an activated clotting time of $300
seconds, although heparin was used selectively in urgent
and emergent cases (eg, aortic transection or aneurysm
rupture). Protamine (1 mg/100 U heparin) was generally
used at case completion to achieve normalization of clot-
ting parameters.
SCI diagnosis and management. SCI after TEVAR
was deﬁned as any new lower extremity motor or sensory
deﬁcit not attributable to other causes (eg, epidural hema-
toma, intracranial pathology, peripheral neuropathy, or
neuropraxia). Patients underwent a gross neurologic exam-
ination in the operating room whenever possible. Patients
who had a documented change from their preoperative
neurologic examination noted at the ﬁrst postoperative
examination were considered to have immediate SCI,
whereas those who experienced an interval of normal post-
operative function, followed by injury recognition, wereconsidered to have a delayed presentation. Consultation
with neurology or conﬁrmatory imaging with spinal
magnetic resonance imaging, or both, were obtained in
equivocal cases.
Patients were admitted postoperatively to a dedicated
cardiothoracic intensive care unit for hourly neurologic
assessment and continuous hemodynamic monitoring. If
SCI developed and the patient did not have a CSF drain,
a drain was placed immediately (usually #1 hour of consul-
tation) by the regional anesthesia service and managed
according to our institutional protocol.3,16 CSF is drained
to keep the pressure #10 mm Hg (14 cm H2O), with
a serial decrease in pressure titrated to neurologic recovery.
To further optimize spinal cord perfusion, other
maneuvers used include volume resuscitation and vaso-
pressor support (goal mean arterial pressure $90 mm
Hg) with or without a drop in spinal drain height, as well
as augmentation of oxygen delivery with maintenance of
a cardiac index >2.0 L/min using vasoactive medications
(if patients have invasive hemodynamic monitoring), pulse
oximetry $96%, and maintenance of hemoglobin above 10
mg/dL.
Although drains in asymptomatic patients are typically
removed 36 to 48 hours after placement, in those with
documented SCI, the drain remains open for at least 72
hours after the onset of symptoms (irrespective of return
of function), or up to 5 days, depending on whether neuro-
logic recovery was observed.
After recovery in the intensive care unit, patients were
transferred to a dedicated cardiovascular nursing ward and
received intensive inpatient physical and occupational
therapy, with disposition to home or to a rehabilitation
unit determined by the degree of neurologic recovery
and functional assessment at time of discharge.
Study end points and deﬁnition of functional
outcome. The primary end points included perioperative
mortality, long-term survival, and overall functional
outcome measured by ambulatory status. Perioperative
mortality was deﬁned as any death #30 days of the
procedure or during the initial hospitalization. Functional
status and survival was determined by a review of the
electronic medical record as well as discussion with the
patient or a close family member. When patients could not
be contacted directly or through family, current survival
status was veriﬁed by query of the Social Security Death
Master ﬁle. Phone interviews were completed with a stan-
dardized questionnaire focusing on functional outcomes
deﬁned by ambulation status and the subjective assessment
of functional improvement (FI) (Appendix, online only).
Patients were asked to describe if they had return to
preoperative global functional status, as well as best
ambulation status. Ambulation status was divided into four
categories: (1) ambulating independently, (2) ambulating
with assistance (cane, walker, etc), (3) nonambulatory, but
mobile (stand/pivot and transfer, wheelchair use), and (4)
bedridden.
Statistical analysis. SAS 9 software (SAS Institute,
Cary, NC) was used to calculate means, standard
Table I. Patient demographics and comorbid medical conditions
Variablesa No SCI SCI OR (95% CI) P
Demographicsb
Patients 550 (90.6) 57 (9.4)
Age, years 63.9 6 15.6 70.5 6 11.2 .002
Male 377 (69.2) 36 (63.2) .34
Comorbiditiesc
Hypertension 149 (27.1) 50 (87.7) 18.7 (8.2-42.7) <.0001
Smoking 78 (14.2) 21 (36.8) 3.4 (1.9-6.2) <.0001
Dyslipidemia 66 (12.0) 25 (43.9) 5.1 (2.8-9.3) <.0001
Renal Insufﬁciency 37 (6.7) 18 (31.6) 6 (3.1-11.7) <.0001
COPD 34 (6.2) 16 (28.1) 5 (2.5-9.9) <.0001
CVOD 14 (2.6) 11 (19.3) 8 (3.4-18.9) <.0001
PVOD 18 (3.3) 7 (12.3) 3.3 (1.3-8.4) .01
CAD 47 (8.6) 10 (17.5) NA .10
CHF 15 (2.7) 2 (3.5) NA .89
Diabetes 26 (4.7) 3 (5.3) NA .90
Composite total 0.9 6 1.6 2.9 6 1.5 NA <.0001
CAD, Coronary artery disease; CHF, congestive heart failure; CI, conﬁdence interval; COPD, chronic obstructive pulmonary disease; CVOD, cerebrovascular
occlusive disease; NA, not applicable; OR, odds ratio; PVOD, peripheral vascular occlusive disease; SCI, spinal cord ischemia.
aCategoric data are shown as number (%) and continuous data as mean 6 standard deviation.
bThe c2 or t-test were used for comparisons, when appropriate.
cMultivariable regression analysis to control for age and sex.
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were used to compare categoric variables in patients with
or without SCI and the Student t-test or Mann-Whitney
tests were used to compare continuous or integer vari-
ables, when indicated. SPSS 20 software (SPSS Inc, Chi-
cago, Ill) was used to estimate long-term survival using
Kaplan-Meier curves. If the individual died, the time (in
months) between TEVAR and death was analyzed as the
survival time. If the patient did not die, time between
TEVAR and December 1, 2011 (the date of SSDI review),
was the survival time. Because the groups were signiﬁcantly
imbalanced with respect to age, sex, and comorbidities,
a Cox logistic regression analysis was performed to account
for potential confounding of these two variables. A value of
P < .05 was considered signiﬁcant.
RESULTS
Study cohort characteristics. Between September
2000 and November 2011, 607 TEVARs were performed,
and SCI was noted in 57 patients (9.4%). A permanent
deﬁcit from preoperative baseline was documented in 26
patients (4.3%). Analysis of the demographic and clinical
variables of patients with and without SCI is reported in
Table I. Notably, development of SCI was more frequent
in older patients (70.5 6 11.2 vs 63.9 6 15.6 years, P ¼
.002), and there were a variety of comorbidities that were
more prevalent in the SCI group (2.9 6 1.5 mean total
number of comorbidities vs 0.9 6 1.6 in no SCI patients;
P < .0001).
Table II further details differences in SCI vs no SCI
patients, including history of open or endovascular aortic
surgery, procedural indications, and operative details.
Notably, previous aortic surgery was not more frequently
associated with development of SCI (P ¼ .23), and acute
dissection was the only indication more likely associatedwith SCI (odds ratio, 2.6; 95% conﬁdence interval [CI],
1.3-5.2; P ¼ .007). Overall, 261 patients (43.6%) received
a preoperative spinal drain, and no difference in the rate of
preoperative spinal drainage was noted between patients
experiencing SCI (21 of 57 [36.8%]) vs no SCI (240 of
550 [43.6%]; P ¼ .52). No differences were detected
when comparing patients with and without SCI regarding
procedural urgency, proximal aortic coverage zones, open
or endovascular conduit use, prophylactic spinal drain
use, or frequency of subclavian revascularization. However,
there was a signiﬁcant difference in the mean number of
aortic stent grafts used in the repair of patients with SCI
(2.1 6 1.1 in no SCI vs 2.4 6 0.93 in SCI; P ¼ .0007).
Procedural outcome data and length of stay are high-
lighted in Table III. As expected, SCI patients had signiﬁ-
cantly greater length of stay (15.5 6 12.3 vs 8.4 6 11.5
days; P < .0001). SCI patients also more commonly had
pulmonary complications (odds ratio, 3.2; 95% CI, 1.5-
6.7; P ¼ .002) and experienced a greater average number
of total complications (exclusive of SCI, 0.7 6 1 vs 0.4 6
.8; P ¼ .04), even when controlling for age, sex, and
procedural urgency. Despite differences in complication
rates, in-hospital mortality was similar between the two
groups (P ¼ .49).
Functional outcomes. Table IV reports outcomes of
the 57 patients with SCI and depicts condition on
discharge, disposition, and FI during follow-up. One-third
of patients were discharged home, and the remaining 33
(57.9%) were transferred to an inpatient facility. Delayed
SCI was documented in 40 patients, with 25 of these
(62.5%) reporting some degree of neurologic recovery and
independently ambulating or ambulating with minimal
assistance (eg, cane) at hospital discharge. Function status
improved after discharge in three additional patients in the
delayed SCI subgroup (28 of 40 [70%] with FI, in total).
Table III. Complications, length of stay, and mortality
after thoracic endovascular aortic repair (TEVAR) with
and without spinal cord ischemia (SCI)a
Outcomesb
No SCI
(n ¼ 550)
SCI
(n ¼ 57) P
Length of stay, days 8.4 6 11.5 15.5 6 12.3 <.0001
In-hospital death 35 (6.4) 5 (8.8) .49
Complication
Otherc 60 (10.9) 5 (8.8) .62
Pulmonary 36 (6.6) 11 (19.3) .002
Renal 27 (4.9) 6 (10.5) .11
Ischemic 24 (4.4) 2 (3.5) >.99
Bleeding 22 (4.0) 4 (7.0) .29
Cardiac 19 (3.5) 3 (5.3) .45
Gastrointestinal 14 (2.6) 2 (3.5) .66
Wound 7 (1.3) 2 (3.5) .20
Total complications
(95% CI)
0.4 6 0.81
(0.3-0.5)
0.65 6 1
(0.4-0.9)
.04
CI, Conﬁdence interval.
ac2 test or Fisher exact test when indicated.
bCategoric data are shown as number (%) and continuous data as mean 6
standard deviation, or as indicated.
cIncludes mycotic, endoleak, and device failure complications of the
endograft.
Table IV. Disposition and outcomes of patients with
spinal cord ischemia
Outcome No. (%) (n ¼ 57)a
Disposition
Home 19 (33.3)
Inpatient facility 33 (57.9)
In-hospital death 5 (8.8)
Condition on discharge
Ambulating independently 7 (12.3)
Ambulating with assistanceb 20 (35.1)
Nonambulatory 9 (15.8)
Bedridden 10 (17.5)
Unknown 6 (10.5)
Best postoperative ambulation status
Ambulating independently 15 (26.3)
Ambulating with assistanceb 16 (28.1)
Nonambulatory 9 (15.8)
Bedridden 10 (17.5)
Unknown 2 (3.5)
Return to pre-op baseline functional status
Yes 13 (22.8)
No 21 (36.8)
Unknown 18 (31.6)
Any improvement in-hospital
Yes 23 (40.3)
No 26 (45.6)
Unknown 8 (14)
Any additional improvement after discharge
Yes 26 (45.6)
No 8 (14)
Unknown 18 (31.6)
Assistance with activities of daily living
Yes 13 (22.8)
No 17 (29.8)
Unknown 22 (38.6)
aFifty-one patients had complete hospital records documenting ambulatory
status; 40 delayed and 12 immediate patients with spinal cord ischemia.
bCane or walker.
Table II. History of aortic surgery, indication for
procedure, and procedural characteristicsa
Variablesb
No SCI
(n ¼ 550)
SCI
(n ¼ 57) P
Previous AAA repair 99 (18) 14 (24.6) .23
Indication
Thoracic aortic aneurysm 248 (45.4) 25 (43.9) .16
Aortic dissection
Chronic type B 74 (13.6) 9 (15.8) .16
Acute 67 (12.3) 13 (22.8) .007
Penetrating aortic ulcer 62 (11.4) 8 (14) .93
Traumatic aortic transection 40 (7.3) 0 .97
Postsurgical 24 (4.4) 1 (1.8) .39
Other 24 (4.4) 0 .96
TAAA 7 (1.3) 1 (1.8) .79
Procedural variables
Urgency
Elective 362 (65.9) 32 (56.1)
Urgent (symptomatic) 91 (16.6) 14 (24.6)
Emergent (rupture) 96 (17.5) 11 (19.3) .25
Proximal coverage zone
0 42 (7.8) 4 (7)
1 15 (2.8) 0
2 217 (40.5) 30 (52.6)
3 134 (25) 12 (21.1)
4 128 (23.9) 11 (19.3) .37
Stents 2.1 6 1.1 2.4 6 0.93 .0007
Open conduit 128 (23.9) 17 (29.8) .28
Carotid-subclavian bypass 74 (13.5) 10 (17.5) .39
Preoperative spinal drain 240 (43.6) 21 (36.8) .324
AAA, Abdominal aortic aneurysm; TAAA, thoracoabdominal aortic aneu-
rysm; TEVAR, thoracic endovascular aortic repair.
ac2 test or Fisher exact test when appropriate.
bCategoric data are shown as number (%) and continuous data as mean 6
standard deviation.
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onset of SCI, where only 25% had documented neurologic
recovery at time of hospital discharge (P ¼ .04), and only
one additional patient had any FI after discharge.
Owing to late deaths and inability to complete follow-
up in some patients (eg, move or no contact information),
comprehensive postdischarge data (including patient ques-
tionnaires) on FI were available for only 34 patients (60%).
In total, 28 of these patients (82%) reported some degree
of additional FI after hospital discharge, but only 13
(38%) experienced complete return to preoperative base-
line functional status. At the last follow-up, 15 of 34
patients (44%) had achieved independent ambulation.
The remaining six patients reported no improvement in
their lower extremity deﬁcit after discharge.
An analysis was performed to determine the relation-
ship of the patient’s functional status at time of hospital
discharge to neurologic recovery as an outpatient. Not
surprisingly, patient ambulatory ability at discharge strongly
correlated with his or her ability to gain measurable im-
provement in ambulation status during the follow-up
interval (Spearman r¼ 0.89; P< .0001; Fig 1). Speciﬁcally,
Fig 1. Ambulation status improvement is demonstrated after
hospital discharge based on the ambulation status determined at
discharge. There were no signiﬁcant differences between the
groups but were notable trends toward less likelihood for
improvement with various degrees of reduced functional status at
discharge. No patients reported a decline in function after
discharge, and no patients with complete paralysis reported any
functional improvement (FI) after discharge. CI, Conﬁdence
interval.
Fig 2. Demonstrates a signiﬁcant difference in survival between
patients with spinal cord ischemia (SCI) vs those without
(P < .001) after thoracic endovascular aortic repair (TEVAR). SE,
Standard error.
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proportion reported subsequent improvement in ambula-
tory status after hospitalization compared with patients
who were bedridden at discharge (P ¼ .07). Of note, no
patient who was bedridden and unable to ambulate at
discharge from the hospital achieved any neurologic
recovery after leaving the hospital.
CSF drainage. Among the patients who developed
SCI, a spinal drain was placed in 54 (94.7%) either preop-
eratively or postoperatively. Three patients did not receive
a drain due to coagulopathy or hemodynamic instability, or
both. Preoperative spinal drains were placed in 23 patients
(40.4%); of these, 15 had data regarding long-term func-
tional outcome after discharge, and 12 of these patients
(80%) experienced some element of neurologic recovery.
Within the postoperative cohort of 31 patients (54.4%)
who received drain placement cohort (19 with outpatient
follow-up data), 73.7% experienced some degree of FI,
which was not different than the preoperative drain group
(P > .99). Further, timing of spinal drain placement was
not differentially associated with survival, ambulation status
on discharge, best postoperative ambulation status, return
to preoperative baseline function, or subjective FI on long-
term follow-up.
Survival. Long-term survival was estimated using
Kaplan-Meier life-table methods (Fig 2). Estimated mean
(6 standard error) survival time for all SCI patients was
37.2 6 4.5 months, which was signiﬁcantly less than
the 71.6 6 3.9 months observed in non-SCI patients
(P < .0006). Notably, the signiﬁcant survival difference
remained when controlling for the increased age of the SCIcohort (hazard ratio, 1.7; 95% CI, 1.2-2.6; P ¼ .007).
Overall survival of patients with any SCI was 64% at 12
months compared with 82% in the non-SCI group (log-
rank P < .001).
Survival times were compared between patients who re-
ported some degree of FI and those who had no recovery,
with survival being dramatically better for those with FI.
The mean survival was 53.9 6 5.9 months for those with
FI and 9.6 6 3.6 months for those without (hazard ratio,
7.6; 95% CI, 2.2-25.8; P ¼ .001; Fig 3). The long-term
survival of individuals experiencing any measurable
improvement was signiﬁcantly better than those who did
not, even when controlling for differences in comorbidities
and demographics between the two subgroups. Strikingly,
survival of SCI patients without FI was only 25% at 12
months compared with 92% in those who reported some
degree of neurologic recovery (log-rank, P < .0001). Inter-
estingly, there was a stepwise increase in survival as the
degree of neurologic recovery increased.
Finally, to determine the effect of timing of neurologic
injury on long-term survival, a comparison between
immediate-onset and delayed-onset SCI is depicted in
Fig 4, A. A signiﬁcant difference in all-cause mortality
(log-rank, P < .0001) was noted between patients who
experienced immediate onset of SCI and those who devel-
oped delayed SCI or with no evidence of neurologic injury.
Despite the detrimental effect of SCI on survival,
patients who returned to baseline function had a further
trend toward improved survival vs those who did not
return to baseline, and their survival approximates that of
patients without SCI (Fig 4, B).
Fig 3. A signiﬁcant difference in survival (P < .0001) is present
depending on whether the patients demonstrated any functional
improvement (FI) after suffering spinal cord ischemia (SCI). The
1-year survival was 92% for patients with FI and 25% for those
without any neurologic recovery. SE, Standard error; TEVAR,
thoracic endovascular aortic repair.
Fig 4. A, Differential survival is noted between patients with
return to preoperative neurologic baseline status vs those without
return to baseline if spinal cord ischemia (SCI) developed
(P ¼ .03) after thoracic endovascular aortic repair (TEVAR).
B, Differential survival is shown between those patients without
SCI vs those with immediate or delayed SCI. Delayed SCI patients
can anticipate similar long-term life expectancy compared with
patients without SCI. RTB, Return to baseline; SE, standard error.
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This study analyzed a large cohort of TEVAR patients
with and without SCI and further compared patients
according to the timing of SCI onset as well as the degree
of FI attained after suffering this complication. Consistent
with previous reports, SCI patients were noted to have
poorer long-term survival than those without this compli-
cation. Interestingly, the timing of SCI and trajectory of
FI were important indicators of the overall prognosis.
SCI is a well-known complication of TEVAR,1,17,18
and despite advancements in risk stratiﬁcation and manage-
ment, the incidence of this complication still ranges
between 2% and 15%.1,3,4,19-21 Indeed, in our own prac-
tice, despite a heightened awareness, liberal CSF drainage,
and the judicious use of adjuncts, such as subclavian revas-
cularization and intensive monitoring, the rate of SCI has
been consistent over time at 9%, with a permanent deﬁcit
rate of 4.3%. Although lower than the usual reported rate
of this complication in open aortic repair, this is certainly
not insigniﬁcant given the devastating impact of SCI.
A variety of risk factors have been associated with SCI
after TEVAR, and although this was not the focus of this
analysis, many of those associations have been corroborated
in this analysis. Many previously identiﬁed risk factors have
been reported, including advanced age, male gender,
a history of renal insufﬁciency, presence (or previous repair)
of an abdominal aneurysm, acute dissection, lumbar/hypo-
gastric artery patency, urgency of TEVAR, aortic coverage
length, and left subclavian artery coverage.1,3,10,15,18,21,22
Notably, a history of open or endovascular aortic repairwas not more frequently associated with the SCI group
(P ¼ .23), although an association was found in a previous
analysis from our group of repaired or unrepaired AAA
with smaller patient numbers.15
Once SCI was recognized, multiple adjuncts were used
in our management algorithm, including spinal drainage,
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tion. Unfortunately, despite aggressive use of spinal
drainage and the positive effect on short-term neurologic
recovery in some patients, the timing of drain placement
(preoperative vs postoperative) did not appear to affect
survival or functional recovery. Although we strongly
support the use of spinal drains for the management of
SCI due to the clear evidence that this can improve neuro-
logic outcomes, it is not clear what beneﬁt a preoperative
drain has over a postoperatively placed drain. In addition,
using this analysis, we are not able to determine whether
any of the available preventative maneuvers affect the
long-term outcomes of SCI.
Perhaps the most interesting ﬁndings from this study
include the prognostic importance of timing and rate of
recovery of SCI after TEVAR. Most patients who develop
SCI after TEVAR have an interval of normal neurologic
function, followed by neurologic deﬁcit (eg, delayed
presentation),21,23 and this was indeed the case in our series,
where 40 SCI patients (70.2%) presented in this manner. Of
the delayed SCI patients, 62.5% experienced at least some
neurologic recovery and were independently ambulating
or ambulating with minimal assistance (eg, cane) at the
time of discharge. This contrasts sharply with the 12
patients with immediate onset of SCI, where only 25%
(P ¼ .04) had any documented improvement at discharge.
Further, although occurrence of any SCI is a marker of poor
long-term survival, this analysis suggests that patients expe-
riencing rapid return of function can anticipate similar life
expectancy compared with patients without SCI (53.9 6
5.9 vs 71.6 6 3.7 months; P ¼ .41) and that those with
full return to their baseline function, not surprisingly, fare
the best. Notably, whether SCI was delayed or immediate
in onset, only 25% of patients without FI were alive at
1 year after TEVAR, compared with 92% of those with FI.
Interestingly, despite the higher overall rate of compli-
cations in patients with SCI, the in-hospital mortality rate
was not different between patients with and without SCI.
Therefore, most of the deaths occurred after hospital
discharge. Unfortunately, we do not know the cause of
death for most of our patients and can only speculate about
the explanation for poorer prognosis in SCI patients. As
demonstrated in this analysis, SCI rarely occurs in isolation,
and it is difﬁcult to account for the confounding effect of
other complications on mortality. In addition, there are
many known risks to the immobility caused by spinal
cord injury that may affect long-term outcome, including
venous thromboembolism/pulmonary embolus, decubitus
ulceration, pneumonia, urinary tract infections, and chronic
institutionalization.24 The pulmonary morbidity associated
with spinal cord injury is also well known,25 and indeed,
our analysis demonstrated a higher rate of pulmonary
complications in our SCI patients (P ¼ .002).
This analysis has several important limitations, in-
cluding a heterogeneous patient population that was clini-
cally diagnosed with SCI, many times without supportive
imaging to conﬁrm SCI. The methodology with which
we identify SCI lends itself to high sensitivity and potentiallylow speciﬁcity and perhaps accounts for the elevated docu-
mented rate of SCI in the series. However, all indications
and all pathologies were included in this analysis, which
further confounds the observed rate of SCI and the poten-
tial trajectory of recovery. In addition, missing data
elements in the clinical follow-up for the SCI cohort may
introduce the possibility of bias that we are unable to
account for in long-term follow-up. Unfortunately, there
is no prevailing comprehensive deﬁnition of SCI after
TEVAR, and we believe that our method is more likely to
overestimate rather than underestimate the occurrence of
this complication. Owing to inconsistent documentation
in medical records, no standardized metric for stratifying
the severity of SCI was possible in this analysis. Further,
the functional outcome assessment tool was based on a non-
validated patient questionnaire that was administered retro-
spectively. Prospective analysis of a larger cohort of TEVAR
patients at high risk of SCI with standardized quality of life
and physical therapy regimens would likely yield a more
deﬁnitive assessment about the effect of timing and severity
on the potential rate of recovery after hospital discharge.
CONCLUSIONS
SCI continues to be a challenging complication of
TEVAR. Although patients with this complication have
signiﬁcantly reduced long-term survival, the subset of
patients with delayed-onset SCI with in-hospital recovery
can anticipate similar life expectancy compared with
TEVAR patients without SCI. Conversely, those patients
with immediate-onset SCI and no improvement in func-
tional status before discharge have a dismal prognosis.
The ﬁndings of this study are important clinical factors
that can be used in planning of postoperative rehabilitation
and patient/family discussions, as well as being taken into
account in preoperative decision making when considering
patients with high-risk for development of SCI.
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1. Where were you discharged to and how long were
you there? (ie, home, nursing home, rehab
facility, Long-term nursing facility, Short-term
nursing facility)
, Home
, Nursing home/Retirement home
, Rehabilitation facility
, Long-term nursing facility
, Short-term nursing facility
, Other ____________________________
, Does not wish to answer
Comments:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
2. Are you able to walk independently?
, Yes
, No
, Does not wish to answer
Comments:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
3. Do you currently have any physical limitations (ie,
cannot perform strenuous activities but can
perform light house duties or ofﬁce work)?
, Yes
, No
, Does not wish to answer
Comments:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
4. Are your current physical abilities different from
the time you were discharged from the hospital
and/or rehab?
, Yes
< If Yes: Have your current physical abilities
improved or worsened?
B Improved
B Worsened
B Does not wish to answer
, No, Unchanged
, Does not wish to answer
Comments:
____________________________________________
____________________________________________
____________________________________________
____________________________________________5. After your discharge from the hospital and/or
rehab, how long did it take for you recover to
your current state of health?
Recovery time: ____________________
Comments:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
6. Do you require any assistance with walking? (ie,
cane, walker, etc)
, Yes
, No
, Does not wish to answer
Comments:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
7. If unable to walk, are you able to use a wheelchair?
, Yes
, No
, Not Applicable
, Does not wish to answer
Comments:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
8. If unable to walk, are you conﬁned to bed more
than 50% of the day?
, Yes
, No
, Not Applicable
, Does not wish to answer
Comments:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
9. Can you care for yourself independentlywith regard
to washing up, getting dressed or preparing meals?
, Yes
, No
, Does not wish to answer
Comments:
____________________________________________
____________________________________________
____________________________________________
____________________________________________
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642.e2 DeSart et al September 201310. Have you undergone any additional procedures
or surgeries since your aortic stenting here at
Shands?
, Yes
< If Yes: What was the procedure and
when/where was it performed? [List
response below, under Comments]
, No
, Does not wish to answer
Comments:
__________________________________________
__________________________________________
__________________________________________
